24 May 2013
Keywords: gene, therapy, angina, clears, ph, ii, trial
Article | 18 March 2002
The results of a Phase II study have shown that a gene therapy,developed by Schering AG subsidiary Berlex Laboratories ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 March 2002
11 March 2002
© 2013 thepharmaletter.com